Sabal Trust’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$33.9M Buy
204,131
+2,176
+1% +$340K 1.88% 13
2024
Q4
$29.2M Sell
201,955
-4,379
-2% -$679K 1.69% 18
2024
Q3
$33.4M Sell
206,334
-56,924
-22% -$9.07M 1.82% 15
2024
Q2
$38.5M Buy
263,258
+199
+0.1% +$29.6K 2.29% 8
2024
Q1
$41.6M Sell
263,059
-3,217
-1% -$512K 2.42% 7
2023
Q4
$41.7M Sell
266,276
-1,379
-0.5% -$211K 2.57% 7
2023
Q3
$41.7M Sell
267,655
-1,494
-0.6% -$247K 2.79% 3
2023
Q2
$44.5M Buy
269,149
+9,777
+4% +$1.58M 2.83% 4
2023
Q1
$40.2M Buy
259,372
+3,249
+1% +$525K 2.8% 6
2022
Q4
$45.2M Sell
256,123
-1,326
-0.5% -$229K 3.08% 2
2022
Q3
$42.1M Buy
257,449
+4,070
+2% +$689K 3.18% 1
2022
Q2
$45M Buy
253,379
+929
+0.4% +$166K 3.23% 1
2022
Q1
$44.7M Buy
252,450
+2,133
+0.9% +$363K 3.1% 3
2021
Q4
$42.8M Buy
250,317
+12,710
+5% +$2.08M 2.72% 7
2021
Q3
$38.4M Sell
237,607
-740
-0.3% -$126K 2.75% 7
2021
Q2
$39.3M Buy
238,347
+4,268
+2% +$707K 2.83% 3
2021
Q1
$38.5M Buy
234,079
+2,709
+1% +$438K 2.86% 3
2020
Q4
$36.4M Buy
231,370
+3,412
+1% +$504K 2.93% 3
2020
Q3
$33.9M Sell
227,958
-4,901
-2% -$725K 2.96% 4
2020
Q2
$32.7M Sell
232,859
-5,776
-2% -$842K 3.06% 3
2020
Q1
$31.3M Sell
238,635
-15,500
-6% -$2.2M 3.52% 2
2019
Q4
$37.1M Buy
254,135
+5,273
+2% +$715K 2.94% 2
2019
Q3
$32.2M Buy
248,862
+3,896
+2% +$513K 2.6% 12
2019
Q2
$34.1M Buy
244,966
+11,347
+5% +$1.57M 3% 2
2019
Q1
$32.7M Buy
233,619
+187,750
+409% +$25.1M 2.9% 4
2018
Q4
$5.92M Buy
45,869
+508
+1% +$70.9K 0.61% 41
2018
Q3
$6.27M Sell
45,361
-594
-1% -$78.9K 0.55% 41
2018
Q2
$5.58M Sell
45,955
-4,465
-9% -$557K 0.53% 41
2018
Q1
$6.46M Sell
50,420
-181,744
-78% -$24.6M 0.62% 39
2017
Q4
$32.4M Sell
232,164
-1,172
-0.5% -$163K 3.31% 4
2017
Q3
$30.3M Sell
233,336
-59,428
-20% -$7.88M 3.03% 6
2017
Q2
$38.7M Buy
292,764
+2,580
+0.9% +$329K 4.07% 1
2017
Q1
$36.1M Sell
290,184
-4,526
-2% -$541K 4.04% 1
2016
Q4
$34M Buy
294,710
+1,511
+0.5% +$175K 3.71% 1
2016
Q3
$34.6M Buy
293,199
+1,849
+0.6% +$224K 3.84% 1
2016
Q2
$35.3M Buy
291,350
+13,755
+5% +$1.56M 4.08% 1
2016
Q1
$30M Buy
277,595
+25,781
+10% +$2.67M 3.56% 3
2015
Q4
$25.9M Sell
251,814
-6,069
-2% -$610K 3.37% 3
2015
Q3
$24.1M Buy
257,883
+17,012
+7% +$1.65M 3.36% 3
2015
Q2
$23.5M Buy
240,871
+876
+0.4% +$87.7K 3.05% 5
2015
Q1
$24.1M Buy
239,995
+6,517
+3% +$663K 3.17% 3
2014
Q4
$24.4M Sell
233,478
-6,028
-3% -$635K 3.16% 3
2014
Q3
$25.5M Buy
239,506
+24,169
+11% +$2.51M 3.43% 3
2014
Q2
$22.5M Buy
215,337
+326
+0.2% +$33K 3.21% 6
2014
Q1
$21.1M Buy
215,011
+359
+0.2% +$33.3K 2.99% 8
2013
Q4
$19.7M Buy
214,652
+2,870
+1% +$264K 2.8% 12
2013
Q3
$18.4M Sell
211,782
-5,430
-2% -$487K 2.85% 10
2013
Q2
$18.6M Buy
+217,212
New +$18.4M 2.98% 5

Other funds holding JNJ

Sabal Trust's JNJ Position: Q1 2025 in Review

Sabal Trust increased its Johnson & Johnson (JNJ) stake by 1.1% in Q1 2025, buying an estimated $340K and bringing the position to 204,131 shares worth $33.9M. The position accounts for 1.88% of the portfolio, ranked #13.

Sabal Trust first reported a position in JNJ in Q2 2013 and has held it in 48 quarters since. The position peaked at $45.2M in Q4 2022. 4,148 funds tracked by Wall St. Rank hold JNJ as of Q1 2025.

  • Sabal Trust held 204,131 shares of Johnson & Johnson worth $33.9M as of Q1 2025.
  • Sabal Trust bought 2,176 Johnson & Johnson shares in Q1 2025, an estimated $340K.
  • Johnson & Johnson made up 1.88% of Sabal Trust's portfolio in Q1 2025, its #13 holding.
  • Sabal Trust first reported a position in Johnson & Johnson in Q2 2013 and has held it in 48 quarters since.
  • Sabal Trust's Johnson & Johnson position peaked at $45.2M in Q4 2022.
  • 4,148 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2025.

Based on Sabal Trust's 13F filing for Q1 2025, filed 23 Apr 2025.